A Philadelphia cardiologist has written a newspaper column questioning the efficacy and cost of Boston Scientific’s Watchman device for stroke prevention. The Watchman left atrial appendage closure device is designed to prevent blood clots that form in the heart’s left atrial appendage from reaching the brain. Boston Scientific (NYSE:BSX) markets it as an alternative to blood-thinning […]
HRS 2019: Study shows no danger to CRM devices from airport body scans
Airport body scanners don’t appear to interfere with pacemakers and defibrillators, and noninvasive neurostimulation through the ear may help treat AFib. Those are but some of the insights coming out of the Heart Rhythm Society’s annual scientific sessions, held this week in San Francisco. Here are some of the research highlights coming out of the […]
HRS releases CIED lead extraction guidelines
The Heart Rhythm Society this week released its guidelines on device lead management and extraction for implantable cardiovascular electronic devices. The new guidelines are the result of a collaboration amongst 10 international organizations, according to the HRS. Included contributing organizations are the HRS, American College of Cardiology, American Heart Association, Asia Pacific Heart Rhythm Society, […]
UPDATE: Medical societies update stroke guidelines
A bevy of cardiac medical societies updated their guidelines for stroke treatment yesterday to take into account new devices and technology, including left atrial appendage occlusion devices, stent retrievers and thrombectomy devices. The American College of Cardiology, Heart Rhythm Society and Society for Cardiovascular Angiography and Interventions have updated their guidelines to include the benefits of left […]
Boston Scientific readies leadless pacer program
Click image to enlarge
Study: Zoll’s LifeVest covers ICD explantation patients
A new study in the journal Heart Rhythm shows the utility of Zoll Medical‘s LifeVest wearable defibrillator for a subset of patients who don’t start out with the device.
More positive data for St. Jude Medical’s Optim defib leads
HRS2014: Perforations, deaths temporarily derail St. Jude’s E.U. Nanostim study
Updated May 12, 2014, at 5:30 p.m. with confirmation from St. Jude Medical.
HRS2014 wrap-up: Medtronic delays ICD therapy, Boston Scientific watches patients from afar, and more
HRS2014: St. Jude Medical and the ghost of product recall past
Battery wars at HRS2014: And the winner is?
A string of presentations and poster sessions during this week’s Heart Rhythm conference pitted device makers against each other in the battle for battery superiority.
- 1
- 2
- 3
- …
- 5
- Next Page »
